Evolution in multimodality management of locally advanced rectal cancer.

Authors

null

Campbell SD Roxburgh

Memorial Sloan Kettering Cancer Center Section of Colorectal Surgery, New York, NY

Campbell SD Roxburgh , Paul Strombom , Patricio B Lynn , Andrea Cercek , Leonard Saltz , Marc Jeffrey Gollub , Christopher H Crane , Abraham Jing-Ching Wu , Jinru Shia , Efsevia Vakiani , Jesse Joshua Smith , Larissa K. F. Temple , Garrett Michael Nash , Jose G. Guillem , Philip Paty , Julio Garcia-Aguilar , Martin R. Weiser

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Multidisciplinary Treatment

Citation

J Clin Oncol 35, 2017 (suppl 4S; abstract 684)

DOI

10.1200/JCO.2017.35.4_suppl.684

Abstract #

684

Poster Bd #

H14

Abstract Disclosures

Similar Posters

Poster

2023 ASCO Gastrointestinal Cancers Symposium

Toxicities and outcomes of neoadjuvant treatment in elderly patients with locally advanced rectal cancer: A scoping review.

Toxicities and outcomes of neoadjuvant treatment in elderly patients with locally advanced rectal cancer: A scoping review.

First Author: Ruba Ahmed Mohammed Hamed

Poster

2013 Gastrointestinal Cancers Symposium

Neoadjuvant capecitabine and oxaliplatin (XELOX) with bevacizumab for locally advanced rectal cancer.

Neoadjuvant capecitabine and oxaliplatin (XELOX) with bevacizumab for locally advanced rectal cancer.

First Author: Junichi Hasegawa